AG˹ٷ

STOCK TITAN

[Form 4] The Baldwin Insurance Group, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

The Form 4 filed with the SEC on 07/02/2025 shows that Baldwin Insurance Group (ticker BWIN) director Joseph John Kadow acquired 645 Class A common shares on 07/01/2025 at a stated price of $0.00, suggesting the shares were granted as part of director compensation rather than bought on the open market. Following the transaction, Kadow’s direct ownership rises to 15,257 shares, while his indirect holding through the Joseph J. Kadow Revocable Trust remains unchanged at 5,000 shares. No derivative securities transactions were reported. Because the purchase represents a small absolute amount and was executed at no cost, the market impact is expected to be minimal; however, it nonetheless signals that the director’s equity stake continues to increase, which many investors view as a modest sign of insider confidence.

Il modulo Form 4 presentato alla SEC il 02/07/2025 mostra che il direttore di Baldwin Insurance Group (ticker BWIN), Joseph John Kadow, ha acquisito 645 azioni ordinarie di Classe A il 01/07/2025 a un prezzo dichiarato di $0,00, suggerendo che le azioni siano state assegnate come parte della retribuzione del direttore e non acquistate sul mercato aperto. Dopo la transazione, la proprietà diretta di Kadow sale a 15.257 azioni, mentre la sua partecipazione indiretta tramite il Joseph J. Kadow Revocable Trust rimane invariata a 5.000 azioni. Non sono state segnalate transazioni su strumenti derivati. Poiché l’acquisto rappresenta un importo assoluto ridotto ed è stato eseguito senza costi, l’impatto sul mercato è previsto minimo; tuttavia, indica comunque che la quota azionaria del direttore continua a crescere, un segnale che molti investitori interpretano come un modesto indice di fiducia interna.

El Formulario 4 presentado ante la SEC el 02/07/2025 muestra que el director de Baldwin Insurance Group (símbolo BWIN), Joseph John Kadow, adquirió 645 acciones ordinarias Clase A el 01/07/2025 a un precio declarado de $0.00, lo que sugiere que las acciones fueron otorgadas como parte de la compensación del director y no compradas en el mercado abierto. Tras la transacción, la propiedad directa de Kadow aumenta a 15,257 acciones, mientras que su participación indirecta a través del Joseph J. Kadow Revocable Trust permanece sin cambios en 5,000 acciones. No se reportaron transacciones con valores derivados. Debido a que la compra representa una cantidad absoluta pequeña y se realizó sin costo, se espera un impacto mínimo en el mercado; sin embargo, señala que la participación accionaria del director sigue aumentando, lo que muchos inversores ven como una señal modesta de confianza interna.

2025� 7� 2�� SEC� 제출� Form 4 문서� 따르�, Baldwin Insurance Group(티커 BWIN) 이사� Joseph John Kadow2025� 7� 1�645� 클래� A 보통�� 명시� 갶� $0.00� 취득� 것으� 나타났습니다. 이 해당 주식� 공개 시장에서 매수� 것이 아니� 이사 보상 차원에서 부여된 것임� 시사합니�. 거래 � Kadow� 직접 소유 주식 수 15,257�� 증갶했으며, Joseph J. Kadow Revocable Trust� 통한 그의 간접 보유5,000�� 변동이 없습니다. 파생상품 거래� 보고되지 않았습니�. 매수갶 작은 절대 규모이고 무상으로 이루어졌� 때문� 시장� 미치� 영향은 미미� 것으� 예상되지�, 이사갶 계속해서 지분을 늘리� 있다� 점은 내부자의 신뢰� 나타내 작은 신호� 많은 투자자들� 보고 있습니다.

Le formulaire 4 déposé auprès de la SEC le 02/07/2025 indique que le directeur de Baldwin Insurance Group (symbole BWIN), Joseph John Kadow, a acquis 645 actions ordinaires de Classe A le 01/07/2025 à un prix déclaré de 0,00 $, ce qui suggère que ces actions ont été attribuées dans le cadre de la rémunération du directeur plutôt qu’achetées sur le marché libre. Suite à cette opération, la détention directe de Kadow s’élève à 15 257 actions, tandis que sa participation indirecte via le Joseph J. Kadow Revocable Trust reste inchangée à 5 000 actions. Aucune transaction sur titres dérivés n’a été signalée. Étant donné que cet achat représente un montant absolu faible et a été effectué sans coût, l’impact sur le marché est attendu comme minimal ; cependant, cela indique que la participation du directeur continue d’augmenter, ce que de nombreux investisseurs considèrent comme un signe modéré de confiance interne.

Das am 02.07.2025 bei der SEC eingereichte Formular 4 zeigt, dass der Direktor von Baldwin Insurance Group (Ticker BWIN), Joseph John Kadow, am 01.07.2025 645 Class A Stammaktien zu einem angegebenen Preis von $0,00 erworben hat, was darauf hindeutet, dass die Aktien im Rahmen der Vergütung des Direktors gewährt wurden und nicht auf dem freien Markt gekauft wurden. Nach der Transaktion steigt Kadows direkter Besitz auf 15.257 Aktien, während sein indirekter Besitz über den Joseph J. Kadow Revocable Trust unverändert bei 5.000 Aktien bleibt. Es wurden keine Transaktionen mit Derivaten gemeldet. Da der Kauf einen geringen absoluten Betrag darstellt und ohne Kosten erfolgte, wird die Marktauswirkung voraussichtlich minimal sein; dennoch signalisiert dies, dass der Aktienanteil des Direktors weiter steigt, was viele Investoren als ein bescheidenes Zeichen für Insidervertrauen sehen.

Positive
  • Director’s stake increased: acquisition of 645 additional shares raises direct ownership to 15,257, signaling continued insider alignment.
Negative
  • Immaterial size: 645 shares is negligible relative to BWIN’s total float and was acquired at $0, limiting informational value to investors.

Insights

TL;DR: Board member added 645 shares via grant; positive signal but quantitatively immaterial to BWIN valuation.

The filing records a routine equity award, boosting the director’s direct stake by roughly 4% (645÷14,612 prior shares). No cash outlay occurred, so it does not reflect active buying conviction; still, the absence of selling and the continued accumulation modestly align insider incentives with shareholders. With BWIN’s likely multi-million-share float, the added shares will not affect supply-demand dynamics nor EPS. Overall impact is neutral for valuation, slightly positive for sentiment.

TL;DR: Routine director stock grant supports alignment, but size too small to alter governance risk profile.

Regular equity grants to outside directors are common best-practice for aligning oversight with shareholder interests. Kadow now holds over 20,000 combined direct and indirect shares, increasing his economic exposure. No red flags such as option backdating or accelerated vesting appear. Because the grant follows standard disclosure timelines and uses form language, governance transparency remains intact. Materiality, however, is low; investors should monitor for larger aggregate insider trends before drawing strategic conclusions.

Il modulo Form 4 presentato alla SEC il 02/07/2025 mostra che il direttore di Baldwin Insurance Group (ticker BWIN), Joseph John Kadow, ha acquisito 645 azioni ordinarie di Classe A il 01/07/2025 a un prezzo dichiarato di $0,00, suggerendo che le azioni siano state assegnate come parte della retribuzione del direttore e non acquistate sul mercato aperto. Dopo la transazione, la proprietà diretta di Kadow sale a 15.257 azioni, mentre la sua partecipazione indiretta tramite il Joseph J. Kadow Revocable Trust rimane invariata a 5.000 azioni. Non sono state segnalate transazioni su strumenti derivati. Poiché l’acquisto rappresenta un importo assoluto ridotto ed è stato eseguito senza costi, l’impatto sul mercato è previsto minimo; tuttavia, indica comunque che la quota azionaria del direttore continua a crescere, un segnale che molti investitori interpretano come un modesto indice di fiducia interna.

El Formulario 4 presentado ante la SEC el 02/07/2025 muestra que el director de Baldwin Insurance Group (símbolo BWIN), Joseph John Kadow, adquirió 645 acciones ordinarias Clase A el 01/07/2025 a un precio declarado de $0.00, lo que sugiere que las acciones fueron otorgadas como parte de la compensación del director y no compradas en el mercado abierto. Tras la transacción, la propiedad directa de Kadow aumenta a 15,257 acciones, mientras que su participación indirecta a través del Joseph J. Kadow Revocable Trust permanece sin cambios en 5,000 acciones. No se reportaron transacciones con valores derivados. Debido a que la compra representa una cantidad absoluta pequeña y se realizó sin costo, se espera un impacto mínimo en el mercado; sin embargo, señala que la participación accionaria del director sigue aumentando, lo que muchos inversores ven como una señal modesta de confianza interna.

2025� 7� 2�� SEC� 제출� Form 4 문서� 따르�, Baldwin Insurance Group(티커 BWIN) 이사� Joseph John Kadow2025� 7� 1�645� 클래� A 보통�� 명시� 갶� $0.00� 취득� 것으� 나타났습니다. 이 해당 주식� 공개 시장에서 매수� 것이 아니� 이사 보상 차원에서 부여된 것임� 시사합니�. 거래 � Kadow� 직접 소유 주식 수 15,257�� 증갶했으며, Joseph J. Kadow Revocable Trust� 통한 그의 간접 보유5,000�� 변동이 없습니다. 파생상품 거래� 보고되지 않았습니�. 매수갶 작은 절대 규모이고 무상으로 이루어졌� 때문� 시장� 미치� 영향은 미미� 것으� 예상되지�, 이사갶 계속해서 지분을 늘리� 있다� 점은 내부자의 신뢰� 나타내 작은 신호� 많은 투자자들� 보고 있습니다.

Le formulaire 4 déposé auprès de la SEC le 02/07/2025 indique que le directeur de Baldwin Insurance Group (symbole BWIN), Joseph John Kadow, a acquis 645 actions ordinaires de Classe A le 01/07/2025 à un prix déclaré de 0,00 $, ce qui suggère que ces actions ont été attribuées dans le cadre de la rémunération du directeur plutôt qu’achetées sur le marché libre. Suite à cette opération, la détention directe de Kadow s’élève à 15 257 actions, tandis que sa participation indirecte via le Joseph J. Kadow Revocable Trust reste inchangée à 5 000 actions. Aucune transaction sur titres dérivés n’a été signalée. Étant donné que cet achat représente un montant absolu faible et a été effectué sans coût, l’impact sur le marché est attendu comme minimal ; cependant, cela indique que la participation du directeur continue d’augmenter, ce que de nombreux investisseurs considèrent comme un signe modéré de confiance interne.

Das am 02.07.2025 bei der SEC eingereichte Formular 4 zeigt, dass der Direktor von Baldwin Insurance Group (Ticker BWIN), Joseph John Kadow, am 01.07.2025 645 Class A Stammaktien zu einem angegebenen Preis von $0,00 erworben hat, was darauf hindeutet, dass die Aktien im Rahmen der Vergütung des Direktors gewährt wurden und nicht auf dem freien Markt gekauft wurden. Nach der Transaktion steigt Kadows direkter Besitz auf 15.257 Aktien, während sein indirekter Besitz über den Joseph J. Kadow Revocable Trust unverändert bei 5.000 Aktien bleibt. Es wurden keine Transaktionen mit Derivaten gemeldet. Da der Kauf einen geringen absoluten Betrag darstellt und ohne Kosten erfolgte, wird die Marktauswirkung voraussichtlich minimal sein; dennoch signalisiert dies, dass der Aktienanteil des Direktors weiter steigt, was viele Investoren als ein bescheidenes Zeichen für Insidervertrauen sehen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KADOW JOSEPH JOHN

(Last) (First) (Middle)
C/O THE BALDWIN INSURANCE GROUP, INC.
4211 W. BOY SCOUT BLVD., SUITE 800

(Street)
TAMPA FL 33607

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Baldwin Insurance Group, Inc. [ BWIN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/01/2025 A 645 A $0 15,257 D
Class A Common Stock 5,000 I By Joseph J. Kadow Revocable Trust of 2008
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Seth Cohen, as Attorney-in-Fact, for Joseph John Kadow 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did BWIN director Joseph John Kadow report in the Form 4?

He acquired 645 Class A common shares on 07/01/2025 at a reported price of $0.

How many Baldwin Insurance Group shares does Kadow now own?

After the transaction he holds 15,257 shares directly and 5,000 shares indirectly via a trust.

Were any derivative securities involved in this filing?

No. Table II shows no derivative securities acquired or disposed of.

Does the transaction indicate insider buying conviction?

Because the shares were granted at $0, it reflects routine compensation more than open-market purchasing power.

Is the transaction likely to impact BWIN’s stock price?

Given the small share count, the filing is not expected to have a material price impact.
Baldwin Insurance Group

NASDAQ:BWIN

BWIN Rankings

BWIN Latest News

BWIN Latest SEC Filings

BWIN Stock Data

2.17B
69.94M
0.88%
103.86%
8.06%
Insurance Brokers
Insurance Agents, Brokers & Service
United States
TAMPA